cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.14752142
title: Additional file 4 of Investigation of long non-coding RNAs as regulatory players of grapevine response to powdery and downy mildew infection

description: Additional file 4: Gene Ontology distribution for all 3 categories for mRNAs coexpressing with PM and DM-responsive lncRNAs and direct Gene Ontology (GO) Count representing the most frequent GO terms in the Biological Processes category.
DOI: 10.6084/m9.figshare.14752139
title: Additional file 3 of Investigation of long non-coding RNAs as regulatory players of grapevine response to powdery and downy mildew infection

description: Additional file 3: Co-expressing powdery and downy mildew-responsive Vitis vinifera lncRNAs and mature mRNAs at Pearson correlation coefficient &gt;= 0.9 (using CoExpress v1.5), including all the positively and negatively co-related co-expressing pairs based on Pearson correlation coefficient using the PERL Script.
DOI: 10.6084/m9.figshare.14752133
title: Additional file 1 of Investigation of long non-coding RNAs as regulatory players of grapevine response to powdery and downy mildew infection

description: Additional file 1: Table S1. Details of transcriptomic data collected from NCBI-SRA database.
DOI: 10.6084/m9.figshare.14752129
title: Additional file 8 of Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity

description: Additional file 8: Supplementary Table 6. Metabolites displaying significant changes in abundances in patients without clinical improvement (n = 48).
DOI: 10.6084/m9.figshare.14752126
title: Additional file 7 of Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity

description: Additional file 7: Supplementary Table 5. Metabolites displaying significant changes in abundances in patients with clinical improvement (n = 16).
DOI: 10.6084/m9.figshare.14752123
title: Additional file 6 of Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity

description: Additional file 6: Supplementary Table 4. Differentially abundant metabolites between lower (DAS28-CRP ≤ 3.2) and higher (DAS28-CRP &gt; 3.2) disease activity groups.
DOI: 10.6084/m9.figshare.14752120
title: Additional file 5 of Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity

description: Additional file 5: Supplementary Table 3. Demographic characteristics of discovery cohort samples (n = 128) divided into lower (DAS28-CRP ≤ 3.2) and higher disease activity (DAS28-CRP &gt; 3.2).
DOI: 10.6084/m9.figshare.14752114
title: Additional file 3 of Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity

description: Additional file 3: Supplementary Table 2. Subject characteristics of 12 patients (12 samples) from the validation cohort.
DOI: 10.6084/m9.figshare.14752111
title: Additional file 2 of Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity

description: Additional file 2: Supplementary Table 1. Subject characteristics of 64 patients (128 samples) from the discovery cohort.
DOI: 10.6084/m9.figshare.14752061
title: Additional file 1 of SaQuant: a real-time PCR assay for quantitative assessment of Staphylococcus aureus

description: Additional file 1.
DOI: 10.6084/m9.figshare.14752039
title: Additional file 1 of Conspecific odor cues induce different vocal responses in serrate-legged small treefrogs, but only in the absence of acoustic signals

description: Additional file 1.
DOI: 10.6084/m9.figshare.14752036
title: Additional file 4 of Analysis of single-cell RNA sequencing data based on autoencoders

description: Additional file 4. Excel file of the metrics calculated for the MCA datasets. Each tab is related to a tested approach and shows the calculated metrics and used method.
DOI: 10.6084/m9.figshare.14752033
title: Additional file 3 of Analysis of single-cell RNA sequencing data based on autoencoders

description: Additional file 3. Excel file of the metrics calculated for the PIC datasets. Each tab is related to a tested approach and shows the calculated metrics and used method.
DOI: 10.6084/m9.figshare.14752030
title: Additional file 2 of Analysis of single-cell RNA sequencing data based on autoencoders

description: Additional file 2. Excel file of the metrics calculated for the PBMC datasets. Each tab is related to a tested approach and shows the calculated metrics and used method.
DOI: 10.25952/qh6f-cc31
title: Investigating the challenges of online English Language instruction in the wake of the COVID-19 crisis

description: This data set is a series of reflective diaries recorded as part of a project entitled "Investigating the challenges of online English Language instruction in the wake of the COVID-19 crisis". This project has the authority number of HE20-117 from the Human Research Ethics Committee (HREC) at the University of New England. Data collection was completed on the 4th of June 2021. The data set is comprised of a number of semi-structured reflective teaching diary entries. The reflective diary entries were gathered from a single active participant over the period of three teaching cycles. The reflective diaries entries have been entered into an NVivo file as they are currently being coded by the active members of the research team. These data will be analysed in order to derive themes in the reflective diaries that map the single participant's experiences teaching English language in a full online mode in the period after the COVID-19 pandemic. These data will support the research by enabling insight to be drawn around the challenges of online English language instruction in the wake of the COVID-19 crisis.
description: This data set is a series of reflective diaries recorded as part of a project entitled "Investigating the challenges of online English Language instruction in the wake of the COVID-19 crisis". This project has the authority number of HE20-117 from the Human Research Ethics Committee (HREC) at the University of New England. Data collection was completed on the 4th of June 2021. The data set is comprised of a number of semi-structured reflective teaching diary entries. The reflective diary entries were gathered from a single active participant over the period of three teaching cycles. The reflective diaries entries have been entered into an NVivo file as they are currently being coded by the active members of the research team. These data will be analysed in order to derive themes in the reflective diaries that map the single participant's experiences teaching English language in a full online mode in the period after the COVID-19 pandemic. These data will support the research by enabling insight to be drawn around the challenges of online English language instruction in the wake of the COVID-19 crisis.
DOI: 10.6084/m9.figshare.14753199
title: CSF1Fc treatment post-fracture_Raw Data.xlsx

description: This dataset contains raw data obtained from mouse experiments aimed to investigate the potential of CSF1-Fc as a pro-anabolic therapeutic after fracture.
DOI: 10.5519/qd.uluo69mc
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (389 records)
DOI: 10.5281/zenodo.4915772
title: Foot steps

description: This contains daily footstep by 45 participants for a research.
DOI: 10.5281/zenodo.4915771
title: Foot steps

description: This contains daily footstep by 45 participants for a research.
DOI: 10.6084/m9.figshare.14753376.v1
title: Mirobial count and relative abundance data of Duroc pigs

description: Microbial count and relative abundance of 47 Duroc pigs at different classification levels
DOI: 10.6084/m9.figshare.14753376
title: Mirobial count and relative abundance data of Duroc pigs

description: Microbial count and relative abundance of 47 Duroc pigs at different classification levels
DOI: 10.15151/esrf-es-427424131
title: Stability of ordered arrays of tiny supported platinum clusters exposed to gases

description: We aim at exploring the stability of ordered arrays of supported tiny Pt clusters under pre-catalytic conditions (i.e. exposed to low pressures of O2, CO, CO+O2 and increasing temperature). We already showed that Pt clusters organize on a template consisting of a thin alumina film on Ni3Al(111) with a density 3 or 9 times higher than palladium, depending on the growth conditions. These tailored ordered arrays open the way to explore the emerging topic of single-atom catalysis by using surface science techniques in order to understand the link between atomic-scale properties and catalytic performance. By combining GISAXS and GIXRD to in situ monitor the clusters' growth and (dis-)organization, we intend to i) follow the structural and morphological evolution of the clusters arrays and the substrate when exposed to gases and ii) determine the pressure and temperature limits up to which catalytic studies can be performed, while keeping a good spatial organization.
DOI: 10.5517/ccdc.csd.cc265r38
title: CCDC 2031309: Experimental Crystal Structure Determination

description: Related Article: Atsushi Seki, Yoshiaki Takahashi|2021|Tetrahedron Lett.|74|153130|doi:10.1016/j.tetlet.2021.153130
DOI: 10.5517/ccdc.csd.cc268fdb
title: CCDC 2033891: Experimental Crystal Structure Determination

description: Related Article: Nilanjana Mukherjee, Tanmay Chatterjee|2021|J.Org.Chem.|86|7881|doi:10.1021/acs.joc.1c00861
DOI: 10.5517/ccdc.csd.cc26f7xt
title: CCDC 2038526: Experimental Crystal Structure Determination

description: Related Article: Ting Sun, Zilong Zhang, Jianbin Xu, Lusheng Liang, Chi-Lun Mai, Lu Ren, Qin Zhou, Yaming Yu, Bao Zhang, Peng Gao|2021|Dyes Pigm.|193|109469|doi:10.1016/j.dyepig.2021.109469
DOI: 10.5517/ccdc.csd.cc26f7yv
title: CCDC 2038527: Experimental Crystal Structure Determination

description: Related Article: Ting Sun, Zilong Zhang, Jianbin Xu, Lusheng Liang, Chi-Lun Mai, Lu Ren, Qin Zhou, Yaming Yu, Bao Zhang, Peng Gao|2021|Dyes Pigm.|193|109469|doi:10.1016/j.dyepig.2021.109469
DOI: 10.5517/ccdc.csd.cc26f80y
title: CCDC 2038529: Experimental Crystal Structure Determination

description: Related Article: Ting Sun, Zilong Zhang, Jianbin Xu, Lusheng Liang, Chi-Lun Mai, Lu Ren, Qin Zhou, Yaming Yu, Bao Zhang, Peng Gao|2021|Dyes Pigm.|193|109469|doi:10.1016/j.dyepig.2021.109469
DOI: 10.5517/ccdc.csd.cc26f81z
title: CCDC 2038530: Experimental Crystal Structure Determination

description: Related Article: Ting Sun, Zilong Zhang, Jianbin Xu, Lusheng Liang, Chi-Lun Mai, Lu Ren, Qin Zhou, Yaming Yu, Bao Zhang, Peng Gao|2021|Dyes Pigm.|193|109469|doi:10.1016/j.dyepig.2021.109469
DOI: 10.5517/ccdc.csd.cc26hp2h
title: CCDC 2040856: Experimental Crystal Structure Determination

description: Related Article: Koichi Mitsudo, Yoshiaki Kobashi, Kaito Nakata, Yuji Kurimoto, Eisuke Sato, Hiroki Mandai, Seiji Suga|2021|Org.Lett.|23|4322|doi:10.1021/acs.orglett.1c01256
DOI: 10.5517/ccdc.csd.cc26hp3j
title: CCDC 2040857: Experimental Crystal Structure Determination

description: Related Article: Koichi Mitsudo, Yoshiaki Kobashi, Kaito Nakata, Yuji Kurimoto, Eisuke Sato, Hiroki Mandai, Seiji Suga|2021|Org.Lett.|23|4322|doi:10.1021/acs.orglett.1c01256
DOI: 10.5517/ccdc.csd.cc26jl7l
title: CCDC 2041729: Experimental Crystal Structure Determination

description: Related Article: Nilanjana Mukherjee, Tanmay Chatterjee|2021|J.Org.Chem.|86|7881|doi:10.1021/acs.joc.1c00861
DOI: 10.5517/ccdc.csd.cc26jl8m
title: CCDC 2041730: Experimental Crystal Structure Determination

description: Related Article: Nilanjana Mukherjee, Tanmay Chatterjee|2021|J.Org.Chem.|86|7881|doi:10.1021/acs.joc.1c00861
DOI: 10.5517/ccdc.csd.cc26kqbv
title: CCDC 2042817: Experimental Crystal Structure Determination

description: Related Article: Yidong Liu, Joseph A. Izzo, David McLeod, Sebastijan Ričko, Esben B. Svenningsen, Thomas B. Poulsen, Karl Anker Jrgensen|2021|J.Am.Chem.Soc.|143|8208|doi:10.1021/jacs.1c03923
DOI: 10.5517/ccdc.csd.cc26mkxb
title: CCDC 2044602: Experimental Crystal Structure Determination

description: Related Article: Nilanjana Mukherjee, Tanmay Chatterjee|2021|J.Org.Chem.|86|7881|doi:10.1021/acs.joc.1c00861
DOI: 10.5517/ccdc.csd.cc26wgk4
title: CCDC 2052186: Experimental Crystal Structure Determination

description: Related Article: Nilanjana Mukherjee, Tanmay Chatterjee|2021|J.Org.Chem.|86|7881|doi:10.1021/acs.joc.1c00861
DOI: 10.5517/ccdc.csd.cc26wgl5
title: CCDC 2052187: Experimental Crystal Structure Determination

description: Related Article: Nilanjana Mukherjee, Tanmay Chatterjee|2021|J.Org.Chem.|86|7881|doi:10.1021/acs.joc.1c00861
DOI: 10.5517/ccdc.csd.cc273dwn
title: CCDC 2058861: Experimental Crystal Structure Determination

description: Related Article: Guang-Qing Wang, Xiao-Feng Huang, Chu-Huang Wu, Yong Shen, Song-Liang Cai, Jun Fan, Wei-Guang Zhang, Sheng-Run Zheng|2021|Polyhedron|205|115284|doi:10.1016/j.poly.2021.115284
DOI: 10.5517/ccdc.csd.cc274qfk
title: CCDC 2060118: Experimental Crystal Structure Determination

description: Related Article: Ting Sun, Zilong Zhang, Jianbin Xu, Lusheng Liang, Chi-Lun Mai, Lu Ren, Qin Zhou, Yaming Yu, Bao Zhang, Peng Gao|2021|Dyes Pigm.|193|109469|doi:10.1016/j.dyepig.2021.109469
DOI: 10.5517/ccdc.csd.cc275lcd
title: CCDC 2060953: Experimental Crystal Structure Determination

description: Related Article: Jiyoung Kim, Eun Jeong Yoo|2021|Org.Lett.|23|4256|doi:10.1021/acs.orglett.1c01173
DOI: 10.5517/ccdc.csd.cc27d6yt
title: CCDC 2067326: Experimental Crystal Structure Determination

description: Related Article: Zeineb Ouerghi, Imen Dridi, Thierry Roisnel, Riadh Kefi|2021|J.Mol.Struct.|1242|130721|doi:10.1016/j.molstruc.2021.130721
DOI: 10.5517/ccdc.csd.cc27fy6v
title: CCDC 2068977: Experimental Crystal Structure Determination

description: Related Article: Ikram Jomaa, Noureddine Issaoui, Thierry Roisnel, Houda Marouani|2021|J.Mol.Struct.|1242|130730|doi:10.1016/j.molstruc.2021.130730
DOI: 10.5517/ccdc.csd.cc27j0d6
title: CCDC 2070967: Experimental Crystal Structure Determination

description: Related Article: Dong-yu Zhu, Xue-jing Zhang, Ming Yan|2021|Org.Lett.|23|4228|doi:10.1021/acs.orglett.1c01193
DOI: 10.5517/ccdc.csd.cc27ld7h
title: CCDC 2073256: Experimental Crystal Structure Determination

description: Related Article: Wo Nie, Shichao Shen, Cheng Ma|2021|Org.Lett.|23|4337|doi:10.1021/acs.orglett.1c01265
DOI: 10.5517/ccdc.csd.cc27ld8j
title: CCDC 2073257: Experimental Crystal Structure Determination

description: Related Article: Wo Nie, Shichao Shen, Cheng Ma|2021|Org.Lett.|23|4337|doi:10.1021/acs.orglett.1c01265
DOI: 10.5517/ccdc.csd.cc27mxsl
title: CCDC 2074730: Experimental Crystal Structure Determination

description: Related Article: Xu-Kuan Qi, Lin Guo, Li-Juan Yao, Han Gao, Chao Yang, Wujiong Xia|2021|Org.Lett.|23|4473|doi:10.1021/acs.orglett.1c01412
DOI: 10.5517/ccdc.csd.cc27mxtm
title: CCDC 2074731: Experimental Crystal Structure Determination

description: Related Article: Xu-Kuan Qi, Lin Guo, Li-Juan Yao, Han Gao, Chao Yang, Wujiong Xia|2021|Org.Lett.|23|4473|doi:10.1021/acs.orglett.1c01412
DOI: 10.6084/m9.figshare.14346176
title: Metadata record for: Updating salamander datasets with phenotypic and stomach content information for two mainland Speleomantes

description: This dataset contains key characteristics about the data described in the Data Descriptor Updating salamander datasets with phenotypic and stomach content information for two mainland Speleomantes. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br>
DOI: 10.6084/m9.figshare.14346176.v1
title: Metadata record for: Updating salamander datasets with phenotypic and stomach content information for two mainland Speleomantes

description: This dataset contains key characteristics about the data described in the Data Descriptor Updating salamander datasets with phenotypic and stomach content information for two mainland Speleomantes. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br>
DOI: 10.6084/m9.figshare.14233055
title: Metadata record for: Database of ab initio L-edge X-ray absorption near edge structure

description: This dataset contains key characteristics about the data described in the Data Descriptor Database of ab initio L-edge X-ray absorption near edge structure. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br>
DOI: 10.6084/m9.figshare.14233055.v1
title: Metadata record for: Database of ab initio L-edge X-ray absorption near edge structure

description: This dataset contains key characteristics about the data described in the Data Descriptor Database of ab initio L-edge X-ray absorption near edge structure. <br> Contents: <br> 1. human readable metadata summary table in CSV format 2. machine readable metadata file in JSON format <br>
DOI: 10.6084/m9.figshare.14753007
title: Supplementary Material for: Reaching Treatment Goals in Psoriasis with Conventional Systemic Drugs: How Long Are We Willing to Wait?

description: <b><i>Objectives:</i></b> The purpose of this study was to investigate the attainment of treatment goals according to the European Consensus Programme (ECP-TGs) from 2011 in patients with moderate to severe psoriasis (Pso) treated with the first conventional systemic therapy and to identify factors that might compromise the attainment of these treatment goals. <b><i>Methods:</i></b> In a multicenter, prospective observational study, patients with moderate to severe Pso, defined as either body surface area (BSA) &gt;10% or psoriasis area severity index (PASI) &gt;10 and dermatology life quality index (DLQI) &gt;10, received a conventional systemic therapy that could be modified at each follow-up visit over the course of 18 months. All subjects signed an informed consent form, were ≥18 years of age as well as systemic therapy naïve, and had regular study visits at months 3, 6, 9, 12, and 18 after baseline. Among others and in addition to demographic and disease-related characteristics at baseline, we documented BSA, PASI, DLQI, and the physician-reported attainment of treatment goals at each follow-up visit. Factors related to a failure in achieving the ECP-TGs (i.e., either Δ PASI ≥75 or Δ PASI ≥50 and &lt;75 with a DLQI ≤5) at month 18 were investigated by multiple logistic regression. Descriptive results are presented as the mean ± SD for interval data, and absolute as well as relative frequencies for nominal data. For this part of the analysis, data at baseline and months 6, 12, and 18 are presented. <b><i>Results:</i></b> A total of 133 Pso patients with a mean age and disease duration of 49.5 ± 14.4 and 15.6 ± 12.8 years, respectively, were included in the analysis; 54.1% (<i>n</i> = 72) were male. The mean baseline disease-related outcomes were: BSA: 21.5 ± 15.8%, PASI: 13.7 ± 7.14, and DLQI: 12.0 ± 6.11. The most common conventional systemic therapies initiated at baseline were fumaric acid esters (<i>n</i> = 74, 55.6%), methotrexate (<i>n</i> = 46, 34,6%), and ciclosporin (<i>n</i> = 6, 4.5%). The ECP-TGs were achieved by 58 patients (43.6%) at month 6, 86 patients (64.7%) at month 12, and 97 patients (72.9%) at month 18. An optimized reduced logistic regression model identified the presence of onycholysis/nail dystrophy at two or more digits to be associated with failing to attain the ECP-TGs (OR 10.7, 95% CI 2.5–46.7, <i>p</i> = 0.002). <b><i>Conclusion:</i></b> Patients with onycholysis/nail dystrophy at two or more digits were identified as having a higher risk of not achieving ECP-TGs under conventional systemic therapy. The ECP-TGs from 2011 were attained by 43.6% of our patients 6 months after starting conventional systemic therapies. In the era of safe, fast, and efficacious Pso therapies, much higher treatment goals might be achieved during therapy. New treatment goals are only of use if patients and dermatologists strive to attain them.
DOI: 10.6084/m9.figshare.14753007.v1
title: Supplementary Material for: Reaching Treatment Goals in Psoriasis with Conventional Systemic Drugs: How Long Are We Willing to Wait?

description: <b><i>Objectives:</i></b> The purpose of this study was to investigate the attainment of treatment goals according to the European Consensus Programme (ECP-TGs) from 2011 in patients with moderate to severe psoriasis (Pso) treated with the first conventional systemic therapy and to identify factors that might compromise the attainment of these treatment goals. <b><i>Methods:</i></b> In a multicenter, prospective observational study, patients with moderate to severe Pso, defined as either body surface area (BSA) &gt;10% or psoriasis area severity index (PASI) &gt;10 and dermatology life quality index (DLQI) &gt;10, received a conventional systemic therapy that could be modified at each follow-up visit over the course of 18 months. All subjects signed an informed consent form, were ≥18 years of age as well as systemic therapy naïve, and had regular study visits at months 3, 6, 9, 12, and 18 after baseline. Among others and in addition to demographic and disease-related characteristics at baseline, we documented BSA, PASI, DLQI, and the physician-reported attainment of treatment goals at each follow-up visit. Factors related to a failure in achieving the ECP-TGs (i.e., either Δ PASI ≥75 or Δ PASI ≥50 and &lt;75 with a DLQI ≤5) at month 18 were investigated by multiple logistic regression. Descriptive results are presented as the mean ± SD for interval data, and absolute as well as relative frequencies for nominal data. For this part of the analysis, data at baseline and months 6, 12, and 18 are presented. <b><i>Results:</i></b> A total of 133 Pso patients with a mean age and disease duration of 49.5 ± 14.4 and 15.6 ± 12.8 years, respectively, were included in the analysis; 54.1% (<i>n</i> = 72) were male. The mean baseline disease-related outcomes were: BSA: 21.5 ± 15.8%, PASI: 13.7 ± 7.14, and DLQI: 12.0 ± 6.11. The most common conventional systemic therapies initiated at baseline were fumaric acid esters (<i>n</i> = 74, 55.6%), methotrexate (<i>n</i> = 46, 34,6%), and ciclosporin (<i>n</i> = 6, 4.5%). The ECP-TGs were achieved by 58 patients (43.6%) at month 6, 86 patients (64.7%) at month 12, and 97 patients (72.9%) at month 18. An optimized reduced logistic regression model identified the presence of onycholysis/nail dystrophy at two or more digits to be associated with failing to attain the ECP-TGs (OR 10.7, 95% CI 2.5–46.7, <i>p</i> = 0.002). <b><i>Conclusion:</i></b> Patients with onycholysis/nail dystrophy at two or more digits were identified as having a higher risk of not achieving ECP-TGs under conventional systemic therapy. The ECP-TGs from 2011 were attained by 43.6% of our patients 6 months after starting conventional systemic therapies. In the era of safe, fast, and efficacious Pso therapies, much higher treatment goals might be achieved during therapy. New treatment goals are only of use if patients and dermatologists strive to attain them.
DOI: 10.6084/m9.figshare.14753028
title: Supplementary Material for: Clinical Trials and Skin of Color: The Example of Hidradenitis Suppurativa

description: Medicine
DOI: 10.6084/m9.figshare.14753028.v1
title: Supplementary Material for: Clinical Trials and Skin of Color: The Example of Hidradenitis Suppurativa

description: Medicine
DOI: 10.6084/m9.figshare.14714682
title: Gene expression FPKM

description: Gene expression FPKM readsFastQ data are available at NCBI SRA (SRP308455).<br><br>
DOI: 10.6084/m9.figshare.14714685
title: TS Diastema GO enrichment

description: Time series analysis of diastema region FastQ data are available at NCBI SRA (SRP308455).<br>
DOI: 10.6084/m9.figshare.14714685.v1
title: TS Diastema GO enrichment

description: Time series analysis of diastema region FastQ data are available at NCBI SRA (SRP308455).<br>